TABLE 3.

χ² Analysis and ORs of acute toxicities for men who were or were not taking MHSs and were treated for prostate cancer with the use of definitive IMRT¹

Toxicity	MHS nonusers with events, n (%)	MHS users with events, n (%)	Chi-square P	OR (95% CI)	P
Genitourinary
Grades 2–4	683 (34)	67 (31)	0.33	0.94 (0.69, 1.29)	0.71
Grades 3–4	116 (6)	11 (5)	0.76	0.96 (0.50, 1.83)	0.90
Gastrointestinal
Grades 2–4	122 (6)	14 (6)	0.88	1.12 (0.63, 2.00)	0.70
Grades 3–4	13 (1)	0 (0)	0.63	MNR2	—

¹IMRT, intensity-modulated radiation therapy; MHS, men’s health supplement; MNR, model not run.

²Because there were too few events.